Key Insights

Highlights

Success Rate

97% trial completion (above average)

Published Results

38 trials with published results (26%)

Research Maturity

111 completed trials (76% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.7%

4 terminated out of 147 trials

Success Rate

96.5%

+9.9% vs benchmark

Late-Stage Pipeline

16%

23 trials in Phase 3/4

Results Transparency

34%

38 of 111 completed with results

Key Signals

38 with results97% success

Data Visualizations

Phase Distribution

122Total
Not Applicable (59)
Early P 1 (1)
P 1 (11)
P 2 (28)
P 3 (17)
P 4 (6)

Trial Status

Completed111
Unknown11
Withdrawn8
Recruiting6
Terminated4
Not Yet Recruiting4

Trial Success Rate

96.5%

Benchmark: 86.6%

Based on 111 completed trials

Clinical Trials (147)

Showing 20 of 20 trials
NCT05910502Not ApplicableCompleted

Project AFECT (Autism Family Empowerment Coaching and Training Program)

NCT07818460Not Yet Recruiting

Risk Factors and Prognosis of Autism Spectrum Disorder

NCT06934915Early Phase 1Recruiting

Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder

NCT05176808Not ApplicableCompleted

Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)

NCT00365859Phase 3CompletedPrimary

Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)

NCT02947880Phase 2WithdrawnPrimary

Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology

NCT02265094Not ApplicableCompletedPrimary

Associative Memory in Autism Spectrum Disorder

NCT00337571Phase 3Completed

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

NCT00332241Phase 3CompletedPrimary

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

NCT07521371Enrolling By Invitation

Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years

NCT01805128Not ApplicableCompleted

Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum

NCT06227780Not ApplicableRecruiting

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

NCT06859918Not ApplicableRecruiting

Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder

NCT00095420Not ApplicableCompleted

Relationship Training for Children With Autism and Their Peers

NCT04805957Not ApplicableEnrolling By Invitation

Validation Digital Bio-markers During Sulforaphane Treatment.

NCT02677051Phase 2Active Not Recruiting

Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

NCT07106840Completed

Autism Traits in Adolescents With Social Anxiety Disorder: Associations With Parental Broader Autism Phenotype

NCT04100863Withdrawn

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism

NCT04788537Not ApplicableCompleted

Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders

NCT03170453Not ApplicableCompletedPrimary

Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

Scroll to load more

Research Network

Activity Timeline